Volume 17, Issue 1
Research Article

Evaluating water quality using power priors to incorporate historical information

Yuyan Duan

Corresponding Author

E-mail address: yuduan@vt.edu

Department of Statistics, Virginia Tech, Blacksburg, VA 24061‐0439, U.S.A.

Department of Statistics, Virginia Tech, Blacksburg, VA 24060‐0439, U.S.A.Search for more papers by this author
Keying Ye

Department of Statistics, Virginia Tech, Blacksburg, VA 24061‐0439, U.S.A.

Search for more papers by this author
Eric P. Smith

Department of Statistics, Virginia Tech, Blacksburg, VA 24061‐0439, U.S.A.

Search for more papers by this author
First published: 13 September 2005
Citations: 39

Abstract

To assess water quality standards, measurements of water quality under the Clean Water Act are collected on a regular basis over a period of time. The data are analyzed to evaluate the percentage of samples exceeding the standard. One problem is that current data are limited by the time range and consequently the sample size is inadequate to provide necessary precision in parameter estimation. To address this issue, we present a Bayesian approach using a power prior to incorporate historical data and/or the data collected at adjacent stations. We develop a modified power prior approach and discuss its properties under the normal mean model. Several sets of water quality data are studied to illustrate the implementation of the power prior approach and its differences from alternative methods. Copyright © 2005 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 39

  • Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control, Pharmaceutical Statistics, 10.1002/pst.2018, 19, 5, (613-625), (2020).
  • PA‐CRM: A continuous reassessment method for pediatric phase I oncology trials with concurrent adult trials, Biometrics, 10.1111/biom.13217, 0, 0, (2020).
  • Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control, Biometrical Journal, 10.1002/bimj.201800395, 62, 2, (361-374), (2019).
  • Bayesian hypothesis testing with frequentist characteristics in clinical trials, Contemporary Clinical Trials, 10.1016/j.cct.2019.105858, 87, (105858), (2019).
  • A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints, Therapeutic Innovation & Regulatory Science, 10.1177/2168479019862531, (216847901986253), (2019).
  • Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2019.1657133, (1-18), (2019).
  • Bayesian hierarchical methods for meta-analysis combining randomized-controlled and single-arm studies, Statistical Methods in Medical Research, 10.1177/0962280218754928, 28, 5, (1293-1310), (2018).
  • Bayesian clinical trial design using historical data that inform the treatment effect, Biostatistics, 10.1093/biostatistics/kxy009, 20, 3, (400-415), (2018).
  • Modified power prior with multiple historical trials for binary endpoints, Statistics in Medicine, 10.1002/sim.8019, 38, 7, (1147-1169), (2018).
  • Propensity‐score‐based priors for Bayesian augmented control design, Pharmaceutical Statistics, 10.1002/pst.1918, 18, 2, (223-238), (2018).
  • Power priors based on multiple historical studies for binary outcomes, Biometrical Journal, 10.1002/bimj.201700246, 61, 5, (1201-1218), (2018).
  • A practical Bayesian adaptive design incorporating data from historical controls, Statistics in Medicine, 10.1002/sim.7897, 37, 27, (4054-4070), (2018).
  • Incorporating historical models with adaptive Bayesian updates, Biostatistics, 10.1093/biostatistics/kxy053, (2018).
  • Dynamic borrowing through empirical power priors that control type I error, Biometrics, 10.1111/biom.12835, 74, 3, (874-880), (2017).
  • Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspects, Pharmaceutical Statistics, 10.1002/pst.1843, 17, 2, (169-181), (2017).
  • Adaptive power priors with empirical Bayes for clinical trials, Pharmaceutical Statistics, 10.1002/pst.1814, 16, 5, (349-360), (2017).
  • Statistical modeling for Bayesian extrapolation of adult clinical trial information in pediatric drug evaluation, Pharmaceutical Statistics, 10.1002/pst.1807, 16, 4, (232-249), (2017).
  • The Sequential Probability Ratio Test: An efficient alternative to exact binomial testing for Clean Water Act 303(d) evaluation, Journal of Environmental Management, 10.1016/j.jenvman.2017.01.039, 192, (89-93), (2017).
  • Bridging data across studies using frequentist and Bayesian estimation, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2017.1289948, 27, 3, (426-441), (2017).
  • Evaluating Generating Unit Unavailability Using Bayesian Power Priors, IEEE Transactions on Power Systems, 10.1109/TPWRS.2016.2603469, 32, 3, (2315-2323), (2017).
  • Including historical data in the analysis of clinical trials: Is it worth the effort?, Statistical Methods in Medical Research, 10.1177/0962280217694506, (096228021769450), (2017).
  • Enhancing pediatric clinical trial feasibility through the use of Bayesian statistics, Pediatric Research, 10.1038/pr.2017.163, (2017).
  • Adaptive prior weighting in generalized regression, Biometrics, 10.1111/biom.12541, 73, 1, (242-251), (2016).
  • Improving Hierarchical Models Using Historical Data with Applications in High-Throughput Genomics Data Analysis, Statistics in Biosciences, 10.1007/s12561-016-9156-x, 9, 1, (73-90), (2016).
  • Bayesian assurance and sample size determination in the process validation life-cycle, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2016.1148717, 27, 1, (159-174), (2016).
  • On the Use of Co-Data in Clinical Trials, Statistics in Biopharmaceutical Research, 10.1080/19466315.2016.1174149, 8, 3, (345-354), (2016).
  • Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods, Statistical Methods in Medical Research, 10.1177/0962280216631359, (096228021663135), (2016).
  • Non‐inferiority and networks: inferring efficacy from a web of data, Pharmaceutical Statistics, 10.1002/pst.1729, 15, 1, (54-67), (2015).
  • The power prior: theory and applications, Statistics in Medicine, 10.1002/sim.6728, 34, 28, (3724-3749), (2015).
  • How to test hypotheses if you must, Pharmaceutical Statistics, 10.1002/pst.1667, 14, 2, (139-150), (2015).
  • Bayesian Approach to Utilize Historical Control Data in Clinical Trials, Japanese Journal of Biometrics, 10.5691/jjb.36.25, 36, 1, (25-50), (2015).
  • Expert Elicitation of Study Weights for Bayesian Analysis and Meta-Analysis, Journal of Mixed Methods Research, 10.1177/1558689814553850, 10, 2, (168-181), (2014).
  • Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors, Statistics in Medicine, 10.1002/sim.6359, 34, 4, (613-629), (2014).
  • Use of historical control data for assessing treatment effects in clinical trials, Pharmaceutical Statistics, 10.1002/pst.1589, 13, 1, (41-54), (2013).
  • Incorporation of historical data in the analysis of randomized therapeutic trials, Contemporary Clinical Trials, 10.1016/j.cct.2011.06.002, 32, 6, (848-855), (2011).
  • Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials, Biometrics, 10.1111/j.1541-0420.2011.01564.x, 67, 3, (1047-1056), (2011).
  • Bayesian Design of Noninferiority Trials for Medical Devices Using Historical Data, Biometrics, 10.1111/j.1541-0420.2011.01561.x, 67, 3, (1163-1170), (2011).
  • A note on the power prior, Statistics in Medicine, 10.1002/sim.3722, 28, 28, (3562-3566), (2009).
  • Using power priors to improve the binomial test of water quality, Journal of Agricultural, Biological, and Environmental Statistics, 10.1198/108571106X110919, 11, 2, (151-168), (2006).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.